Dr. Khor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114Phone+1 617-726-2967
Education & Training
- Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2007 - 2011
- Washington University in St. Louis School of MedicineClass of 2007
Certifications & Licensure
- WA State Medical License 2016 - 2025
- MA State Medical License 2011 - 2018
- American Board of Pathology Pathology - Clinical
- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- 3 citationsFRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitis.Soochan Kim, Eunhwa Ko, Hwan Geun Choi, Daekwon Kim, Monica Luchi
Journal of Translational Autoimmunity. 2023-01-01 - 3 citationsThe Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway.Azlann Arnett, Keagan G. Moo, Kaitlin J. Flynn, Thomas B. Sundberg, Liv Johannessen
Molecular and Cellular Biology. 2021-08-24 - 18 citationsTonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiomeIsabelle Marié, Lara Brambilla, Doua F Azzouz, Ze Chen, Gisele V Baracho
Elife. 2021-08-11
Press Mentions
- Autoimmunity in down Syndrome Arises from Rapid Immune AgingJanuary 14th, 2022
- Does the Vaccine Cut Your Risk of Getting Long COVID?October 21st, 2021
- Brickell Biotech to Host Key Opinion Leader Webinar on DYRK1A and Its Role in AutoimmunitySeptember 17th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: